DE:C6K0 / Avalo Therapeutics, Inc. - Net Long/Short Value

Avalo Therapeutics, Inc.
DE ˙ DB
€ 11,60 ↓ -0.12 (-1.02%)
2026-06-05
PREÇO DA AÇÃO
DE:C6K0 / Avalo Therapeutics, Inc. - Net Long/Short Value
Esta página fornece as avaliações líquidas longas/curtas para cada participação institucional relatada através de arquivamentos 13F ou NPORT. Para calcular o valor líquido longo/curto, somamos o valor de patrimônio ao valor da opção de compra e subtraímos o valor da opção de venda. Fundos que relatam posições emprestadas curtas apresentarão valores de patrimônio como negativos. Posições líquidas longas terão números positivos na coluna líquido longo/curto, e posições líquidas curtas terão valores negativos nessa coluna.
Proprietário Valor de Patrimônio
($1000)
Valor de Compra
($1000)
Valor de Venda
($1000)
Líquido Longo/Curto
($1000)
OMERS ADMINISTRATION Corp
Acuta Capital Partners, Llc
Key FInancial Inc
Commodore Capital Lp
Dimensional Fund Advisors Lp
Artia Global Partners LP
Jennison Associates Llc
Fmr Llc
Susquehanna Portfolio Strategies, LLC
Velan Capital Investment Management LP
Aquatic Capital Management LLC
Deutsche Bank Ag\
Renaissance Technologies Llc
Millennium Management Llc
Boothbay Fund Management, Llc
Td Asset Management Inc
Adage Capital Partners Gp, L.l.c.
Hudson Bay Capital Management LP
Moody Aldrich Partners Llc
HighVista Strategies LLC
Geode Capital Management, Llc
DV Trading LLC
Bnp Paribas Arbitrage, Sa
Ameriprise Financial Inc
Ikarian Capital, LLC
UBS Group AG
Brevan Howard Capital Management LP
T. Rowe Price Investment Management, Inc.
Bvf Inc/il
PFS Partners, LLC
Balyasny Asset Management Llc
Glenmede Trust Co Na
Charles Schwab Investment Management Inc
Kennedy Capital Management, Inc.
Logos Global Management LP
Rosalind Advisors, Inc.
Farther Finance Advisors, LLC
BlackRock, Inc.
Fortitude Family Office, LLC
Morgan Stanley
Persistent Asset Partners Ltd
Caption Management, LLC
Advisor Group Holdings, Inc.
683 Capital Management, LLC
StemPoint Capital LP
State Street Corp
Pivotal bioVenture Partners Investment Advisor LLC
Affinity Asset Advisors, LLC
Vanguard Fiduciary Trust Co
XTX Topco Ltd
Farallon Capital Management Llc
Two Sigma Advisers, Lp
Wells Fargo & Company/mn
Seven Fleet Capital Management LP
Northern Trust Corp
Jane Street Group, Llc
Ra Capital Management, L.p.
Avoro Capital Advisors LLC
Vanguard Capital Management Llc
Vanguard Global Advisers, LLC
Envestnet Asset Management Inc
Two Sigma Investments, Lp
Barclays Plc
Silver Grove Financial Group, Inc.
Jpmorgan Chase & Co
NAN FUNG TRINITY (HK) Ltd
Us Bancorp \de\
Nantahala Capital Management, LLC
Soleus Capital Management, L.P.
Squarepoint Ops LLC
ExodusPoint Capital Management, LP
Great Point Partners Llc
Perceptive Advisors Llc
Citadel Advisors Llc
Shay Capital LLC
Qube Research & Technologies Ltd
Goldman Sachs Group Inc
Caligan Partners LP
Prelude Capital Management, Llc
Rtw Investments, Lp
Standard Life Aberdeen plc
Susquehanna International Group, Llp
Group One Trading, L.p.
Boxer Capital Management, LLC
TCG Crossover Management, LLC
Westfield Capital Management Co Lp
Vanguard Group Inc
Quadrature Capital Ltd
Hrt Financial Lp
Royal Bank Of Canada
Bank Of America Corp /de/
DLD Asset Management, LP
Orbimed Advisors Llc
Parallel Advisors, LLC
Point72 Asset Management, L.P.
Marshall Wace, Llp
AlphaCentric Advisors LLC
EverSource Wealth Advisors, LLC
Man Group plc
Exome Asset Management LLC
EntryPoint Capital, LLC
Activest Wealth Management
Jump Financial, LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:AVTX US$ 13,10
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista